The New Era of SGLT2 Inhibitors: Transforming Diabetes, Heart...

bir ses eklendi Other

2026-08-17 08:22:58 -

The New Era of SGLT2 Inhibitors: Transforming Diabetes, Heart Failure, and Kidney Care

According to a new report by Polaris Market Research, the global SGLT2 Inhibitors market was valued at USD 18.32 billion in 2025 and is projected to reach USD 33.51 billion by 2034, expanding at a CAGR of 6.90% over the forecast period. Growth is underpinned by rising cardiorenal treatment adoption, expanding type 2 diabetes prevalence, and accelerating new drug approvals across key...

0 Yorumlar 0 hisse senetleri 34 Views 0 önizleme